$XPHYF News
Last published 4y ago
- 4y agoXPHYFXPhyto Signs Letter of Intent for US Manufacturing and Strategic Business OpportunitiesACCESS NewswireVANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / October 4, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to report that it has signed a non-binding Letter of Intent ("LOI") to identify and
- 4y agoXPHYFXPhyto Files Patent Application for Library of Novel Psychedelic CompoundsACCESS NewswireVANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / September 20, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to report that it has filed a patent application for a significant library of nov
- 4y agoXPHYFXPhyto Closes Final Tranche of Fully Subscribed FinancingACCESS NewswireNOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / September 2, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to anno
- 4y agoXPHYFXPhyto Pursues Potential Application of its Oral Dissolvable Biosensor Inflammation Test for Buprenorphine-related Dental DiseaseACCESS NewswireVANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / July 18, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY),(OTCQB:XPHYF), (FSE:4XT) ("XPhyto" or the "Company") is pleased to report a significant potential market opportunity for its oral dissolvable ("ODF
- 4y agoXPHYFXPhyto Pursues Potential Application of its Oral Dissolvable Biosensor Inflammation Test for Buprenorphine-related Dental DiseaseACCESS NewswireVANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / July 15, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY),(OTCQB:XPHYF), (FSE:4XT) ("XPhyto" or the "Company") is pleased to report a significant potential market opportunity for its oral dissolvable ("ODF
- 4y agoXPHYFXPhyto Adds Pharmaceutical Manufacturing Expert Dr. Florian A. Sahr to Its European TeamACCESS NewswireVANCOUVER, BC and UTTENWEILER / ACCESSWIRE / June 8, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to report that Dr. Florian A. Sahr has joined its European operations as Head of Project Managem
- 4y agoXPHYFXPhyto Reports Product Developments on Platform-Based Rotigotine Transdermal Patch for Parkinson's DiseaseACCESS NewswireVANCOUVER, BC, AND UTTENWEILER, GERMANY / ACCESSWIRE / May 9, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to provide a product development report on its Rotigotine transdermal ("TDS") patch, in
- 4y agoXPHYFXPhyto, Biosensors Market and Product Developments on Platform-Based Oral Dissolvable Biosensors for Oral Health and Infectious DiseaseACCESS NewswireVANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / April 11, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to provide a market and product development report on its Sublingual oral dissolvable
- 4y agoXPHYFXPhyto Reports Market and Product Developments on Platform-based Rotigotine Transdermal Patch for Parkinson's DiseaseACCESS NewswireVANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / April 4, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY, OTCQB:XPHYF) ("XPhyto" or the "Company") is pleased to provide a market and product development report on its Rotigotine transdermal ("TDS") patch.
- 4y agoXPHYFXPhyto Closes First Tranche of FinancingACCESS NewswireVANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / March 31, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to announce that further to its news release of March 25, 2022, it has closed the fir
- 4y agoXPHYFXPhyto Provides Progress Update on Psychedelic Medicine Programs and Novel Compounds MilestoneACCESS NewswireVANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / February 22, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to provide an update on its wholly owned subsidiary XPhyto Laboratories Inc. ("XPh
- 4y agoXPHYFXPhyto Reports on its Three Primary Business DivisionsACCESS NewswireVANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / February 8, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to report on its three business divisions as part of its product development, comme
- 4y agoXPHYFXPhyto Executes Covid-ID Lab Sales Contracts with Test Clinics and Pharmacies in Germany as Part of Multi-Product Rollout StrategyACCESS NewswireVANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / February 1, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to announce the execution of Covid-ID Lab sales contracts with both digital life ar
- 4y agoXPHYFXPhyto Provides Update on Integration of 3a-diagnostics GmbHACCESS NewswireVANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / January 24, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to provide an update on the integration of 3a-diagnostics GmbH ("3a") into XPhyto's
- 4y agoXPHYFXPhyto Announces Head of Sales, EuropeACCESS NewswireVANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / January 17, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to announce the appointment of Mr. Drahoslav Zdarek as the Company's Head of Sales,
- 4y agoXPHYFXPhyto signs Distribution Agreement for Czech Republic, rollout planned for Hungary, Slovakia, Ukraine and RussiaACCESS NewswireVANCOUVER, CANADA, and UTTENWEILER, GERMANY / ACCESSWIRE / January 13, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTC:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to announce that it has signed a distribution agreement (the "Agreement") with T
- 4y agoXPHYFXPhyto Epilepsy Clinical Trial Planned in 2022 with Its Proprietary Fast-Dissolving CBD Oral StripsACCESS NewswireVANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / December 15, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to provide an update on the development of its fast-dissolving CBD oral strips. Wi
- 4y agoXPHYFXPhyto Completes Strategic Acquisition of 3a-diagnostics GmbHACCESS NewswireThe acquisition positions XPhyto to be a leading Biosensor producer integrating thin film technology with 3a-diagnostics biosensor technology The acquisition of 3a, a German-based rapid point-of-care diagnostics firm adds IP and a deeply experienced sc
- 4y agoXPHYFXPhyto Therapeutics Announces Stock Option GrantsACCESS NewswireTHIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / December 3, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) (the "Company" or "XPhyto") announces t
- 4y agoXPHYFXPhyto Therapeutics Closes Private Placements for Gross Proceeds of $7,000,0000ACCESS NewswireNOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / November 26, 2021 / XPhyto Therapeutics Corp. ("XPhyto" or the "Company") (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) is pleased to announce that
- 4y agoXPHYFXPhyto Announces CFO AppointmentACCESS NewswireVANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / November 19, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to announce the appointment of Mr. Joseph Meagher as Chief Financial Officer of th
- 5y agoAAZZFABIOACOGFACST+81Investor Summit Group Provides Update on Upcoming Q4 Virtual SummitGlobeNewswireNEW YORK, Nov. 05, 2021 (GLOBE NEWSWIRE) -- The Investor Summit Group, widely recognized for its reputation as the host of North America's largest independent investor conferences, will be hosting the upcoming Q4 Virtual Summit on November 16-17. The e
- 5y agoXPHYFXPhyto Announces Managing Director Appointment, Financing and 3a-diagnostics DevelopmentACCESS NewswireNOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / November 3, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Comp
- 5y agoXPHYFXPhyto Reports Development Update for its Drug Delivery BusinessACCESS NewswireRotigotine transdermal skin patch optimization and pivotal study planning underway Rotigotine patch manufacturing, sales and marketing in preparation Cannabinoid oral dissolvable film (ODF) programs advanced, CBD ODF ready for pilot study Prioritizat
- 5y agoXPHYFXphyto Announces Engagement of Consultants for Marketing and Promotional ActivitiesACCESS NewswireVANCOUVER, BC / ACCESSWIRE / October 8, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the"Company") announces it has entered into extensions to investor relations consulting agreements with each of Knox Communications Inc
- 5y agoXPHYFXPhyto Reports Successful Market Launch and Growing Demand for its 25-minute COVID-19 PCR Test COVID-ID LabACCESS NewswireVANCOUVER, BC and FRANKFURT, GERMANY / ACCESSWIRE / September 8, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY) (OTCQB:XPHYF) (FSE:4XT) ("XPhyto" or the "Company") is pleased to announce the successful market launch of its 25-minute COVID-19 PCR Test COVID-
- 5y agoXPHYFXPhyto Launches First Commercial Biosensor for Oral DiseaseACCESS NewswireBiosensor test dissolves on the tongue and turns bitter indicating the presence of oral inflammation after five minutes Easy and simple at-home self-checks improve oral health and indicate inflammation early on Test successfully registered with the Ge
- 5y agoXPHYFXPhyto's Acquisition Target, 3a-Diagnostics, Reports Breakthrough Identification of COVID-19 Biosensor CandidatesACCESS NewswireFirst saliva activated biosensor molecules identified to diagnose COVID-19 infection using XPhyto's oral dissolvable delivery platform Biosensor candidates are ready for optimization and performance assessment Development of biosensor screening test
- 5y agoARECAURQFAZASFBIOC+22Proactive news headlines including American Resources, Nextleaf Solutions, Versus Systems and Vox RoyaltyGlobeNewswireNew York , July 20, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies: Arizona Silver Exploration Inc (CVE:AZS) (OTC:AZASF) h
- 5y agoXPHYFXPhyto Signs Transformative Acquisition Agreement With 3a-Diagnostics, to Enter Hi-Tech Biosensor Market and Expand Its Diagnostic Product PortfolioACCESS NewswireThe acquisition creates significant commercial development and manufacturing opportunities for XPhyto as well as cost synergies and improved margins on its diagnostic products. The acquisition secures XPhyto an experienced research and development team
- 5y agoXPHYFXPhyto Announces Advertising Agreement with Agora Internet Relations Corp.ACCESS NewswireVANCOUVER, BC / ACCESSWIRE / July 2, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") announces that pursuant to its advertising agreement with AGORA Internet Relations Corp. ("AGORA") dated December 1, 2020 (
- 5y agoALPPAMYZFBSGMBUSXF+15Proactive news headlines including BioSig Technologies, Mirasol Resources, Canada Silver Cobalt Works and Versus SystemsGlobeNewswireNew York , June 30, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies: Alpine 4 Holdings Inc (OTCQB:ALPP) says its two ae
- 5y agoXPHYFXPhyto Supplies 10 Test Centers in Berlin with 25-minute COVID-19 PCR TestACCESS NewswireXPhyto signs master supply agreement with operator of 10 COVID-19 test centers The test will be offered to customers as a rapid PCR test with sample processing on site Commercial operations expected to commence upon delivery of kits VANCOUVER, BC /
- 5y agoXPHYFInvestorBrandNetwork (IBN) Announces Latest Episode of The Bell2Bell Podcast featuring Hugh Rogers, CEO of XPhyto Therapeutics Corp.GlobeNewswireNEW YORK, June 17, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- InvestorBrandNetwork ("IBN"), a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of an exclus
- 5y agoXPHYFXPhyto Therapeutics Corp. Featured in Syndicated Broadcast Covering Latest Progress Report on Mescaline Program for Psychedelic TherapiesGlobeNewswireVANCOUVER, British Columbia, June 15, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- XPhyto Therapeutics Corp. (CSE:XPHY) (OTCQB:XPHYF) (FSE: 4XT), a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutica
- 5y agoAVCOBLONFBNVIFCLGPF+16Proactive news headlines including Marvel Discovery, Tocvan Ventures, Altamira Gold, Water Tower Research and Clean Seed CapitalGlobeNewswireNew York , June 08, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies: Northstar Gold Corp (CSE:NSG) (OTC:NSGCF) (FRA:3WV
- 5y agoXPHYFXPhyto Provides Progress Report on Mescaline Program for Psychedelic TherapiesACCESS NewswireResearch and development lab set up, preliminary mescaline synthesis complete Modified synthesis process developed, mescaline batches manufactured Development of analytical methods and validation, GMP standard operating procedures and manufacturing sc
- 5y agoABMLAURQFCLRMFENTEF+13Proactive news headlines including Aurelius Minerals, NexTech AR Solutions, American Battery Metals and Loop InsightsGlobeNewswireNew York, May 20, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies: Q BioMed Inc (OTCQB:QBIO) hires contract sales force t
- 5y agoXPHYFXPhyto Rapid Point-of-Care COVID-19 PCR Test Offered for Sale in GermanyACCESS NewswireRapid 25-minute point-of-care COVID-19 PCR test available for purchase in Germany commencing May 25, 2021 Volume based pricing competitive with other COVID-19 PCR test products on the market Initial manufacturing capacity secured, additional capacity
- 5y agoABMLBIOCBNVIFBRGGD+21Proactive news headlines including Binovi Technologies, Newrange Gold, Harvest One Cannabis and Milestone ScientificGlobeNewswireNew York , May 13, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies: Binovi Technologies Corp (OTCQB:BNVIF) (CVE
- 5y agoXPHYFXPhyto Provides Update on Drug Formulation and Development BusinessACCESS NewswireRotigotine transdermal human pilot study successfully completed; program advancing to pivotal study Land purchased for construction of commercial drug manufacturing facility in Germany VANCOUVER, BC & BIBERACH, GERMANY / ACCESSWIRE / May 13, 2021 / X
- 5y agoACSTBKLLFBRGGFCLSK+7Proactive news headlines including Power Reit, Delta 9 Cannabis, Bragg Gaming and Acasti PharmaGlobeNewswireNew York, May 07, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies: Power REIT (NYSEAMERICAN:PW)1Q earnings per share surge 27
- 5y agoXPHYFXPhyto Establishes Proof of Concept Station for Point-of-Care 25-minute COVID-19 PCR Test in GermanyACCESS NewswirePilot project includes point-of-care sample collection, PCR processing and final testing of workflow logistics Project is in cooperation with a German pharmacy currently running a COVID-19 test center Rapid results with high accuracy - 20-minute PCR r
- 5y agoXPHYFInvestorBrandNetwork Announces Gamechangers LIVE Interview with XPhyto Therapeutics Corp. CEO and Director Hugh RogersGlobeNewswireLOS ANGELES, May 06, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — InvestorBrandNetwork ("IBN"), a multifaceted financial news and publishing company for private and public entities, today announces that Hugh Rogers, CEO and Director of XPhyto Therapeu
- 5y agoBIOCEMPYFEQTRFINOTF+7Proactive news headlines including Biocept, Phunware, Empress Royalty and One World LithiumGlobeNewswireNew York , April 21, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies: Recruiter.com Group Inc (OTCQB:RCRT) partners with We
- 5y agoCANSFCCWOFCLGUFCODX+21Proactive news headlines including Vuzix Corp, Cloud Nine Web3 Technologies, Fury Gold Mines and Dalrada FinancialGlobeNewswireNew York, April 20, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies: Vuzix Corporation (NASDAQ:VUZI) says Verizon's